Gaush Meditech Ltd (FRA:F7Y)

Market Cap	119.89M
Revenue (ttm)	189.02M
Net Income (ttm)	12.23M
Shares Out	n/a
EPS (ttm)	0.08
PE Ratio	9.81
Forward PE	n/a
Dividend	0.03 (3.90%)
Ex-Dividend Date	Jun 23, 2025

Volume	n/a
Average Volume	147
Open	0.8050
Previous Close	0.7800
Day's Range	0.8050 - 0.8050
52-Week Range	0.5700 - 1.4800
Beta	n/a
RSI	56.37
Earnings Date	Aug 22, 2025

About R1 RCM

Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, re...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 1998
• Employees: 884
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: F7Y

Financial Performance

In 2024, Gaush Meditech's revenue was 1.43 billion, an increase of 1.58% compared to the previous year's 1.41 billion. Earnings were 92.39 million, a decrease of -46.75%.